| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Integrative analysis of multiple gene expression profiles applied to liver cancer study.
|
FEBS Lett
|
2004
|
1.63
|
|
2
|
Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.
|
Ann Surg Oncol
|
2011
|
1.50
|
|
3
|
Enhanced specificity of the p53 family proteins-based adenoviral gene therapy in uterine cervical cancer cells with E2F1-responsive promoters.
|
Cancer Biol Ther
|
2006
|
1.46
|
|
4
|
Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
|
Cancer Res
|
2008
|
1.45
|
|
5
|
Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
|
Carcinogenesis
|
2009
|
1.21
|
|
6
|
Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo.
|
Hepatology
|
2006
|
1.18
|
|
7
|
Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method.
|
Int J Mol Med
|
2009
|
1.13
|
|
8
|
Hormonal activity of AIMP1/p43 for glucose homeostasis.
|
Proc Natl Acad Sci U S A
|
2006
|
1.08
|
|
9
|
Up-regulation of Mac-2 binding protein by hTERT in gastric cancer.
|
Int J Cancer
|
2007
|
1.08
|
|
10
|
Tristetraprolin regulates the stability of HIF-1alpha mRNA during prolonged hypoxia.
|
Biochem Biophys Res Commun
|
2009
|
1.05
|
|
11
|
Effect of polyethylene glycol on gene delivery of polyethylenimine.
|
Biol Pharm Bull
|
2003
|
1.04
|
|
12
|
Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
|
Gastroenterology
|
2009
|
1.00
|
|
13
|
ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.
|
Amino Acids
|
2010
|
1.00
|
|
14
|
Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.
|
Exp Mol Med
|
2007
|
0.99
|
|
15
|
ESM-1 regulates cell growth and metastatic process through activation of NF-κB in colorectal cancer.
|
Cell Signal
|
2012
|
0.99
|
|
16
|
Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines.
|
Int J Oncol
|
2009
|
0.98
|
|
17
|
Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
|
Life Sci
|
2006
|
0.98
|
|
18
|
Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer.
|
Clin Chim Acta
|
2009
|
0.98
|
|
19
|
Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer.
|
J Cancer Res Clin Oncol
|
2008
|
0.98
|
|
20
|
Identification of endothelial cell-specific molecule-1 as a potential serum marker for colorectal cancer.
|
Cancer Sci
|
2010
|
0.97
|
|
21
|
Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer.
|
Cancer
|
2010
|
0.96
|
|
22
|
Liverome: a curated database of liver cancer-related gene signatures with self-contained context information.
|
BMC Genomics
|
2011
|
0.95
|
|
23
|
Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2.
|
Cancer Lett
|
2011
|
0.93
|
|
24
|
Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells.
|
Biochem Biophys Res Commun
|
2008
|
0.92
|
|
25
|
STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human hepatoma cells.
|
Biochem Biophys Res Commun
|
2006
|
0.92
|
|
26
|
Doxorubicin prevents endoplasmic reticulum stress-induced apoptosis.
|
Biochem Biophys Res Commun
|
2005
|
0.91
|
|
27
|
Beta-lapachone, a modulator of NAD metabolism, prevents health declines in aged mice.
|
PLoS One
|
2012
|
0.90
|
|
28
|
Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice.
|
Life Sci
|
2010
|
0.85
|
|
29
|
Gene expression analysis in human gastric cancer cell line treated with trichostatin A and S-adenosyl-L-homocysteine using cDNA microarray.
|
Biol Pharm Bull
|
2004
|
0.83
|
|
30
|
A quantitative analysis of N-myc downstream regulated gene 2 (NDRG 2) in human tissues and cell lysates by reverse-phase protein microarray.
|
Clin Chim Acta
|
2007
|
0.83
|
|
31
|
Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
|
Clin Chim Acta
|
2012
|
0.83
|
|
32
|
Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarray.
|
Biochim Biophys Acta
|
2004
|
0.82
|
|
33
|
The expression of estrogen receptors in hepatocellular carcinoma in Korean patients.
|
Yonsei Med J
|
2006
|
0.82
|
|
34
|
HCNet: a database of heart and calcium functional network.
|
Bioinformatics
|
2006
|
0.81
|
|
35
|
A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA.
|
J Gene Med
|
2006
|
0.81
|
|
36
|
Thalamic T-type Ca²+ channels mediate frontal lobe dysfunctions caused by a hypoxia-like damage in the prefrontal cortex.
|
J Neurosci
|
2011
|
0.81
|
|
37
|
The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer.
|
Oncotarget
|
2014
|
0.80
|
|
38
|
Caspase-mediated cleavage and DNase activity of the translation initiation factor 3, subunit G (eIF3g).
|
FEBS Lett
|
2013
|
0.80
|
|
39
|
Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.
|
J Biol Chem
|
2010
|
0.79
|
|
40
|
Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells.
|
Mol Cells
|
2013
|
0.79
|
|
41
|
Identification of novel regulators of apoptosis using a high-throughput cell-based screen.
|
Mol Cells
|
2007
|
0.78
|
|
42
|
Confirmation of a linkage between H-Ras and MMP-13 expression as well as MMP-9 by chemical genomic approach.
|
Int J Cancer
|
2006
|
0.78
|
|
43
|
Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
|
Ann Surg Oncol
|
2011
|
0.78
|
|
44
|
Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors.
|
Mol Ther
|
2006
|
0.77
|
|
45
|
Gene delivery using a derivative of the protein transduction domain peptide, K-Antp.
|
Biomaterials
|
2009
|
0.77
|
|
46
|
CIIA induces the epithelial-mesenchymal transition and cell invasion.
|
Biochem Biophys Res Commun
|
2009
|
0.77
|
|
47
|
Gene expression profiling in mouse liver infected with Clonorchis sinensis metacercariae.
|
Parasitol Res
|
2009
|
0.77
|
|
48
|
CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo.
|
Carcinogenesis
|
2013
|
0.77
|
|
49
|
Diagnostic accuracy of serum asialo-alpha1-acid glycoprotein concentration for the differential diagnosis of liver cirrhosis and hepatocellular carcinoma.
|
Clin Chim Acta
|
2006
|
0.77
|
|
50
|
High-resolution transcriptome analysis reveals neuropathic pain gene-expression signatures in spinal microglia after nerve injury.
|
Pain
|
2016
|
0.76
|
|
51
|
Role of E2F1 in endoplasmic reticulum stress signaling.
|
Mol Cells
|
2006
|
0.76
|
|
52
|
SH3RF2 functions as an oncogene by mediating PAK4 protein stability.
|
Carcinogenesis
|
2013
|
0.76
|
|
53
|
Knockdown of anterior gradient 2 expression extenuates tumor-associated phenotypes of SNU-478 ampulla of Vater cancer cells.
|
BMC Cancer
|
2014
|
0.75
|
|
54
|
Hepatocellular carcinoma model cell lines with two distinct migration modes.
|
Biochem Biophys Res Commun
|
2006
|
0.75
|
|
55
|
The suppression of zfpm-1 accelerates the erythropoietic differentiation of human CD34+ cells.
|
Biochem Biophys Res Commun
|
2006
|
0.75
|